Osaic Holdings
VTYX

Osaic Holdings’s Ventyx Biosciences VTYX Stock Holding History

Osaic Holdings’s Portfolio VTYX Stock Details VTYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-61
Closed -$190 – 8210
2025
Q3 		$190 Hold
61
– – ﹤0.01% 7699
2025
Q2 		$131 Buy
+61
New +$99 ﹤0.01% 7540
2025
Q1 		– Sell
-519
Closed -$1.14K – 7729
2024
Q4 		$1.14K Sell
519
-205
-28% -$465 ﹤0.01% 6799
2024
Q3 		$1.58K Sell
724
-80
-10% -$184 ﹤0.01% 6698
2024
Q2 		$1.86K Buy
+804
New +$3.34K ﹤0.01% 6624
2024
Q1 		– Sell
-339
Closed -$829 – 7418
2023
Q4 		$829 Buy
339
+78
+30% +$741 ﹤0.01% 6812
2023
Q3 		$9.05K Buy
261
+42
+19% +$1.45K ﹤0.01% 5971
2023
Q2 		$7.18K Sell
219
-109
-33% -$3.76K ﹤0.01% 6135
2023
Q1 		$11K Buy
328
+94
+40% +$3.65K ﹤0.01% 5923
2022
Q4 		$7K Buy
+234
New +$6.93K ﹤0.01% 6147

Other funds holding VTYX

AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Osaic Holdings's VTYX Position: Q4 2025 in Review

Osaic Holdings sold out of Ventyx Biosciences (VTYX) in Q4 2025, closing a stake of 61 shares — an estimated $190 sold.

Osaic Holdings first reported a position in VTYX in Q4 2022 and held it in 10 quarters. The position peaked at $11K in Q1 2023. 139 funds tracked by Wall St. Rank hold VTYX as of Q4 2025.

  • Osaic Holdings reported no remaining Ventyx Biosciences position as of Q4 2025 after selling out during the quarter.
  • Osaic Holdings sold 61 Ventyx Biosciences shares in Q4 2025, an estimated $190.
  • Osaic Holdings first reported a position in Ventyx Biosciences in Q4 2022 and held it in 10 quarters.
  • Osaic Holdings's Ventyx Biosciences position peaked at $11K in Q1 2023.
  • 139 funds tracked by Wall St. Rank held Ventyx Biosciences as of Q4 2025.

Based on Osaic Holdings's 13F filing for Q4 2025, filed 17 Feb 2026.